Remove 2025 Remove Compounding Remove Packaging
article thumbnail

Pharmacy Law and Licensing Highlights 2025

The FDA Law Blog

By Sara M Keup In reviewing some new 2025 pharmacy rules/laws a couple interesting changes caught this bloggers attention: As of December 30, 2024, Missouri has rolled out new rules related to prescription drug delivery requirements. Massachusetts will begin enforcement against non-licensed pharmacy dispensing beginning on May 1, 2025.

article thumbnail

How much does semaglutide cost per month?

The Checkup by Singlecare

The medication is available in both brand-name and compounded forms, although the compounded forms are not FDA approved. Compounded semaglutide is made by special compounding pharmacies rather than pharmaceutical companies. Does insurance cover compounded semaglutide? affected by a shortage).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why demand is rising for secure and climate-controlled gene therapy services

Pharmaceutical Technology

It is critical to understand the supply chain, plan your packaging, storage and distribution lanes, then test the entire process before patient shipments go live. Products are stored and packaged in a dedicated suite by a dedicated team,” explains MacNeir. The requirements When handling personalised medicines, time is of the essence.

article thumbnail

9 Sneaky Thyroid Toxins Hiding in Your Home

The Thyroid Pharmacist

10] Its not only found in obvious sources like plastic containers and packaging, but also in the lining of canned foods and drinks, receipts, toys, electronics, and household items. When grocery shopping, try to purchase items that are packaged in glass and canned foods that are packaged with BPA-free lining. 2024;23(1):22-26.

article thumbnail

Message from the Chair an Exciting Year

ISPE

We defined the path forward for 2023–2025 after a final round of consultations with the Board advisors in July. In addition, we took the Board on tours of Vetter’s facilities for sterile products and through all the production steps: compounding to fill-finish to automated visual inspection and secondary packaging.

article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). These new operating models can help enable and accelerate the efforts of Pharma 4.0™

article thumbnail

Challenges for Net Zero Carbon Pharmaceutical Manufacturing

ISPE

9 In November 2022, the Chinese Pharmacopoeia announced the intention to include a chapter on ambient WFI in the 2025 edition. solvent selection, inhaler propellant replacement, and packaging design) to employee travel and commute policy (e.g., recycled content in packaging, reduction of packaging weights).